FibroGen, Inc.
NOVEL NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF
Last updated:
Abstract:
The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.
Status:
Application
Type:
Utility
Filling date:
22 Aug 2018
Issue date:
8 Aug 2019